Young Sylvia Jean 4

What Happened

• Sylvia Jean Young, a director of Pediatrix Medical Group, Inc. (MD), received a grant of 7,196 restricted shares on May 7, 2026. The Form 4 shows an acquisition at $0.00 (award/grant), so no cash was paid by the insider for these shares. The award was granted under the issuer’s Amended and Restated 2008 Incentive Compensation Plan as part of an annual equity award.

Key Details

• Transaction date: May 7, 2026; Form 4 filed May 11, 2026.
• Transaction type/code: Award/Grant (A); 7,196 shares acquired @ $0.00 (reported value $0).
• Vesting/footnote: Footnote F1 — restricted shares granted under the 2008 Incentive Compensation Plan; shares will vest on May 7, 2027.
• Shares owned after transaction: Not specified in the provided filing summary.
• Remarks/Exhibits: Filing references Exhibit 24.1 (Power of Attorney).

Context

• This was an equity compensation award, not an open-market purchase or sale. Restricted share grants are a routine form of executive/director compensation and typically vest over time; they do not by themselves indicate immediate buying or selling sentiment. Reviewers may note the Form 4 filing date (May 11) relative to the transaction date (May 7) to confirm timeliness under Section 16 reporting rules.